Express Delivery
All orders are shipped with Speedy
Cash on delivery
Reliable and convenient payment methods
Proven quality
Peptides Tested at Janoshik Labs
Express delivery in 1-3 business days.
Each peptide comes with bacteriostatic water.
Ipamorelin is a synthetic pentapeptide from the GHRP (Growth Hormone Releasing Peptides) group, which acts as a selective agonist of the ghrelin receptor (GHS-R1a). Its primary action is related to stimulating the pituitary gland to release growth hormone (GH). Unlike other GHRP peptides, Ipamorelin is characterized by a more selective profile and a lower probability of increasing cortisol and prolactin. In scientific literature, it is often described as one of the most balanced and well-tolerated representatives of this group. In research settings, it is being investigated in relation to muscle growth, tissue recovery, bone health, and metabolic processes.
Ipamorelin is being studied in relation to the following physiological processes:
Stimulation of growth hormone – enhances GH pulses without a significant increase in prolactin and cortisol.
Support for muscle mass – linked to protein synthesis and anabolic processes.
Improved recovery – observed role in regeneration after physical exertion.
Joint and bone health – considered in relation to mineralization and tendon recovery.
Sleep quality – associated with supporting the deep phases of sleep.
Effects on cellular regeneration – studied in relation to IGF-1 and recovery processes.
Metabolic action – an observed link to lipolysis and regulation of fat balance.
Cardioprotective effects – in experimental models, a potential protective effect on cardiac function has been described.
Ipamorelin has been studied in preclinical models and limited clinical trials.
In endocrinology, it is considered due to reliable GH stimulation without significant changes in ACTH, cortisol, and prolactin levels.
In orthopedics and sports medicine, interest is focused on the recovery of muscles, tendons, and bone structures.
In gerontology, it is being investigated for its potential role in age-related changes associated with muscle mass and bone density loss.
In cardiology and neurology, it is considered a possible protective factor against cellular damage and oxidative stress.
In scientific literature, subcutaneous administration in the range of 200–300 μg daily, divided into 1–3 applications, is most commonly described.
For 10 mg + 3 ml bacteriostatic water:
Concentration = 3.3 mg/ml → 0.06 ml = 200 μg
Example values for 10 mg:
0.06 ml = 200 μg
0.12 ml = 400 μg
0.18 ml = 600 μg
0.24 ml = 800 μg
Ipamorelin is included in WADA's prohibited list for professional sports because it can:
stimulate growth hormone release
aid in tissue recovery
positively influence muscle mass and strength
participate in fat reduction processes
Ipamorelin is generally considered well-tolerated in clinical studies. Reported reactions are rare and usually mild:
redness or discomfort at the injection site
headache
fatigue or drowsiness
mild fluid retention
At higher doses, dizziness or temporary changes in appetite may be observed less frequently.
The information has been gathered and systematized from various scientific publications and studies. It serves solely for educational purposes and should not be used for the diagnosis, treatment, or prevention of diseases.